. 2020 Aug 28;26(32):4817–4832. doi: 10.3748/wjg.v26.i32.4817

Table 5.

The comparison of human leukocyte antigen alleles which increase or decrease the gastric cancer/duodenal ulcer risk in gastric cancer and duodenal ulcer subgroups in terms of CagA+(≥ 2) EPIYA-C, n (%)

	GC (≥ 2) EPIYA-C (n = 26, alleles=52)	DU (≥ 2) EPIYA-C (n = 14, alleles=28)	OR	95%CI			P value
	GC (≥ 2) EPIYA-C (n = 26, alleles=52)	DU (≥ 2) EPIYA-C (n = 14, alleles=28)	OR	Minimum	Maximum		P value
HLA-A*02	12 (23)	10 (36)	0.54	0.19		1.47	0.2302
HLA-B*35	12 (23)	4 (14)	1.80	0.52		6.21	0.3527
HLA-DRB1*13	12 (23)	6 (21)	1.10	0.36		3.83	0.8663
HLA-DQA1*01	24 (46)	10 (36)	1.54	0.59		3.97	0.3689
HLA-DRB1*06	12 (23)	8 (28)	0.75	0.26		2.12	0.5889

HLA: Human leukocyte antigen; GC: Gastric cancer; DU: Duodenal ulcer; CI: Confidence interval; OR: Odds ratio.